The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Joseph A. Sparano

Albert Einstein College of Medicine

Bronx

New York 10461

USA

[email]@montefiore.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Albert Einstein College of Medicine, Bronx, New York 10461, USA. 2002 - 2012
  • Montefiore Medical Center - Weiler Division, Professor of Medicine and Women's Health, Albert Einstein College of Medicine, 1825 Eastchester Road, USA. 2010
  • Eastern Cooperative Oncology Group, Philadelphia, USA. 2008

References

  1. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Sparano, J.A., Wang, M., Zhao, F., Stearns, V., Martino, S., Ligibel, J.A., Perez, E.A., Saphner, T., Wolff, A.C., Sledge, G.W., Wood, W.C., Fetting, J., Davidson, N.E. Cancer (2012) [Pubmed]
  2. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. Sparano, J.A., Wang, M., Zhao, F., Stearns, V., Martino, S., Ligibel, J.A., Perez, E.A., Saphner, T., Wolff, A.C., Sledge, G.W., Wood, W.C., Davidson, N.E. J. Natl. Cancer Inst. (2012) [Pubmed]
  3. Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer. Sparano, J.A., Goldstein, L.J., Childs, B.H., Shak, S., Brassard, D., Badve, S., Baehner, F.L., Bugarini, R., Rowley, S., Perez, E.A., Shulman, L.N., Martino, S., Davidson, N.E., Kenny, P.A., Sledge, G.W., Gray, R. Clin. Cancer Res. (2011) [Pubmed]
  4. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Sparano, J.A., Lee, J.Y., Kaplan, L.D., Levine, A.M., Ramos, J.C., Ambinder, R.F., Wachsman, W., Aboulafia, D., Noy, A., Henry, D.H., Von Roenn, J., Dezube, B.J., Remick, S.C., Shah, M.H., Leichman, L., Ratner, L., Cesarman, E., Chadburn, A., Mitsuyasu, R. Blood (2010) [Pubmed]
  5. Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. Sparano, J.A., Vrdoljak, E., Rixe, O., Xu, B., Manikhas, A., Medina, C., Da Costa, S.C., Ro, J., Rubio, G., Rondinon, M., Perez Manga, G., Peck, R., Poulart, V., Conte, P. J. Clin. Oncol. (2010) [Pubmed]
  6. Clinical application of gene expression profiling in breast cancer. Sparano, J.A., Fazzari, M., Kenny, P.A. Surg. Oncol. Clin. N. Am. (2010) [Pubmed]
  7. Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy. Sparano, J.A., Pisano, E.D., White, J.R., Hunt, K.K., Mamounas, E.P., Perez, E.A., Hortobagyi, G.N., Gralow, J.R., Comis, R.L. Breast Cancer Res. Treat. (2010) [Pubmed]
  8. Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase III study. Sparano, J.A., Makhson, A.N., Semiglazov, V.F., Tjulandin, S.A., Balashova, O.I., Bondarenko, I.N., Bogdanova, N.V., Manikhas, G.M., Oliynychenko, G.P., Chatikhine, V.A., Zhuang, S.H., Xiu, L., Yuan, Z., Rackoff, W.R. J. Clin. Oncol. (2009) [Pubmed]
  9. Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer. Sparano, J.A., Moulder, S., Kazi, A., Coppola, D., Negassa, A., Vahdat, L., Li, T., Pellegrino, C., Fineberg, S., Munster, P., Malafa, M., Lee, D., Hoschander, S., Hopkins, U., Hershman, D., Wright, J.J., Kleer, C., Merajver, S., Sebti, S.M. Clin. Cancer Res. (2009) [Pubmed]
  10. Weekly paclitaxel in the adjuvant treatment of breast cancer. Sparano, J.A., Wang, M., Martino, S., Jones, V., Perez, E.A., Saphner, T., Wolff, A.C., Sledge, G.W., Wood, W.C., Davidson, N.E. N. Engl. J. Med. (2008) [Pubmed]
  11. Development of the 21-gene assay and its application in clinical practice and clinical trials. Sparano, J.A., Paik, S. J. Clin. Oncol. (2008) [Pubmed]
  12. HIV-associated lymphoma: the evidence for treating aggressively but with caution. Sparano, J.A. Curr. Opin. Oncol (2007) [Pubmed]
  13. Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide. Sparano, J.A., Moulder, S., Kazi, A., Vahdat, L., Li, T., Pellegrino, C., Munster, P., Malafa, M., Lee, D., Hoschander, S., Hopkins, U., Hershman, D., Wright, J.J., Sebti, S.M. J. Clin. Oncol. (2006) [Pubmed]
  14. TAILORx: trial assigning individualized options for treatment (Rx). Sparano, J.A. Clin. Breast Cancer (2006) [Pubmed]
  15. Clinical application of molecular profiling in breast cancer. Sparano, J.A., Fazzari, M.J., Childs, G. Future. Oncology. (london,. England) (2005) [Pubmed]
  16. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). Sparano, J.A., Lee, S., Chen, M.G., Nazeer, T., Einzig, A., Ambinder, R.F., Henry, D.H., Manalo, J., Li, T., Von Roenn, J.H. J. Clin. Oncol. (2004) [Pubmed]
  17. Human immunodeficiency virus associated lymphoma. Sparano, J.A. Curr. Opin. Oncol (2003) [Pubmed]
  18. Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers. Sparano, J.A., Brown, D.L., Wolff, A.C. Drug. Saf (2002) [Pubmed]
 
WikiGenes - Universities